APOC3 and chronic kidney disease: In a recent study comparing the site-specific glycosylation of ApoC-III in patients across the spectrum from healthy, to those with metabolic syndrome to diabetic patients with chronic kidney disease on hemodialysis, ApoC-III was differentially glycosylated in patients with metabolic syndrome and diabetic hemodialysis compared to controls (37).